US star swimmer Ryan Lochte has been banned for 14 months for receiving intravenous infusion, the US Anti-Doping Agency (USADA) has announced.
Two months ago, he posted a photo on social media of himself receiving an intravenous infusion. That caught the attention of the US Anti-Doping Agency, which launched an investigation.
Now, the six-time gold medalist has been suspended for 14 months. That clock started on May 24, the day he took the IV.
The suspension will last till July, 2019, which means the 12-time Olympic medalist will miss the upcoming US championship in California and world championships in 2019.
Lochte said that he was receiving vitamins, a permitted substance, to enhance his immune system as his wife and child were both ill, Xinhua news agency reported.
But the amount he took was over 100 ml and he had no "therapeutic use" exemption for the infusion, which constituted a anti-doping violation, the USADA explained.
"A rule is a rule and I accept that there is a technical violation," Lochte said, acknowledging his misbehaviour.
--IANS
in/
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
